Inflation Reduction Act

Congress enacted the Inflation Reduction Act which will allow Medicare to negotiate drug prices.

Featured

Jul 8, 2024

Haystack mdpnp Guidance ipay2027 Comment

Jul 8, 2024

Mar 20, 2024

Haystack MPPP Pt 2 Guidance Comments 3.15.24

Mar 20, 2024

Mar 4, 2024

Haystack Part D Redesign Comments

Mar 4, 2024

Sep 20, 2023

Medicare Prescription Payment Plan Guidance

Sep 20, 2023

Jul 31, 2023

Haystack comments on CMS' Information Collection Request for Negotiation Data Elements (CMS-10847)

Jul 31, 2023

Jun 20, 2023

Haystack Submits Feedback on the Counteroffer ICR

Jun 20, 2023

Jun 5, 2023

Haystack provides feedback on the upcoming implementation of the Inflation Reduction Act’s (IRA) provisions related to Medicare Part D redesign

Jun 5, 2023

Apr 14, 2023

Haystack's comments on CMS' issuance of its initial set of guidance on implementation of the Inflation Reduction Act of 2022

Apr 14, 2023

Mar 27, 2023

Haystack's comments on the small biotech exception to the drug negotiation provisions of the Inflation Reduction Act

Mar 27, 2023

Mar 13, 2023

Haystack's Comments in response to CMS' Medicare Part B Inflation Rebate Guidance

Mar 13, 2023

The Haystack Project

Contact Us

Please consider making a tax-deductible donation to support the Haystack Project today.

The Haystack Project is a 501(c)3 nonprofit that brings together patients organizations representing patients suffering from or caring for patients with extremely rare diseases. Our mission is to educate policymakers and other stakeholders about the need for policies that recognize the unique circumstances of extremely rare conditions and treatments and expand incentives critical to ensuring they can reach patients.

The Haystack Project

Act Now

Join Haystack Project

Keep up-to-date with current events at Haystack!

About Us

The Issues

Resources

News & Updates

Contact Us